STOCK TITAN

[Form 4] UNITEDHEALTH GROUP INC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Paul R. Garcia, a director of UnitedHealth Group Inc. (UNH), reported an internal acquisition on 09/23/2025 consisting of 11 common stock units recorded as acquired at $0 as dividend equivalents on vested deferred stock units. The filing shows 2,761 shares beneficially owned directly after the transaction and additional indirect holdings of 2,146 shares via a revocable trust plus 45 and 55 shares via two other trusts. The dividend equivalents vested immediately and carry the same terms as the underlying deferred stock units.

Paul R. Garcia, un direttore di UnitedHealth Group Inc. (UNH), ha riportato un'acquisizione interna il 23/09/2025 che consisteva in 11 azioni ordinarie registrate come acquisite a $0 come dividendi equiparati su azioni differite maturate. Il deposito mostra 2.761 azioni detenute beneficiariamente direttamente dopo la transazione e ulteriori detenzioni indirette di 2.146 azioni tramite un Trust revocabile più 45 e 55 azioni tramite due altri trust. Gli equivalenti a dividendi si sono maturati immediatamente e hanno gli stessi termini delle unità azionarie differite sottostanti.

Paul R. Garcia, un director de UnitedHealth Group Inc. (UNH), reportó una adquisición interna el 23/09/2025 que consistió en 11 acciones comunes registradas como adquiridas a $0 como equivalentes en dividendos sobre unidades de acciones diferidas vestidas. El registro muestra 2.761 acciones poseídas beneficiosamente directamente después de la operación y participaciones indirectas adicionales de 2.146 acciones a través de un fideicomiso revocable más 45 y 55 acciones a través de dos otros fideicomisos. Los equivalentes de dividendos se adjudicaron de inmediato y tienen los mismos términos que las unidades de acciones diferidas subyacentes.

폴 R. 가르시아, UnitedHealth Group Inc.(UNH)의 이사, 2025년 9월 23일에 주식 단위를 11주의 일반 주식으로 내부 취득을 보고했으며 이는 $0로 기록된 배당금 상당액으로 부여된 가속 vesting 주식단위에 속합니다. 신고서에 거래 직후 직접적으로 유리하게 소유한 2,761주의 보유 주식과, 해지 가능한 신탁을 통한 2,146주의 간접 보유, 그리고 두 개의 다른 신탁을 통한 4555주의 보유가 추가로 기재되어 있습니다. 배당금 상당액은 즉시 부여되었고 기초가 되는 지연 보상 주식단위와 동일한 조건을 가집니다.

Paul R. Garcia, directeur chez UnitedHealth Group Inc. (UNH), a déclaré une acquisition interne le 23/09/2025 consistant en 11 actions ordinaires enregistrées comme acquises pour $0 en tant qu’équivalents de dividende sur des unités d’actions différées acquises. Le dossier indique 2 761 actions détenues directement après la transaction et des positions indirectes supplémentaires de 2 146 actions via une fiducie révocable ainsi que 45 et 55 actions via deux autres fiducies. Les équivalents de dividendes se sont acquis immédiatement et conservent les mêmes conditions que les unités d’actions différées sous-jacentes.

Paul R. Garcia, ein Direktor der UnitedHealth Group Inc. (UNH), meldete eine interne Übernahme am 23.09.2025, die aus 11 Stammaktien bestand, die als zugewiesen zu $0 als Dividendenäquivalente auf vested deferred stock units verbucht wurden. Die Einreichung zeigt 2.761 Aktien, die unmittelbar nach der Transaktion direkt vorteilshaft gehalten werden, sowie zusätzliche indirekte Bestände von 2.146 Aktien über einen widerruflichen Trust sowie 45 und 55 Aktien über zwei weitere Trusts. Die Dividendenäquivalente wurden sofort fällig und behalten dieselben Bedingungen wie die zugrunde liegenden deferred stock units.

بول R. غارسيا، مدير في UnitedHealth Group Inc. (UNH)، أبلغ عن استحواذ داخلي في 23/09/2025 يتكون من 11 وحدة أسهم عادية مسجلة كمكتسبة بمقدار $0 كتعارضات أرباح على وحدات الأسهم المؤجلة المحقة. يظهر الملف وجود 2,761 سهم مملوكون نيابة مباشرة بعد الصفقة و2,146 سهم إضافية بشكل غير مباشر عبر صندوق يمكن سحبه وتحريره، بالإضافة إلى 45 و55 سهمًا عبر صندوقين آخرين. استحقاق التعويضات عن الأرباح فورًا وتحمل نفس شروط وحدات الأسهم المؤجلة الأساسية.

保罗 R. 加西亚, UnitedHealth Group Inc. (UNH) 的董事,报告了在2025/09/23进行的内部收购,涉及11 股普通股,登记为以$0取得的股息等价物,用于已归属的递延股票单位。该备案显示交易后直接受益所有权的2,761 股,以及通过可撤销信托的额外间接持有2,146 股,再加上通过另外两个信托的4555股。股息等价物已立即归属,条款与基础的递延股票单位相同。

Positive
  • Transparent disclosure of dividend-equivalent issuance and beneficial ownership breakdown
  • Dividend equivalents vested immediately and are treated the same as underlying deferred stock units
Negative
  • None.

Insights

TL;DR: Insider received a small number of vested dividend-equivalent shares, modestly increasing direct holdings.

The Form 4 discloses a routine issuance of 11 shares as dividend equivalents that immediately vested and carry the same restrictions as the underlying deferred stock units. This type of transaction is standard compensation mechanics for directors and does not reflect a purchase or open-market trade. The reporting indicates transparent disclosure and the use of a revocable trust for indirect holdings, which is common for estate and tax planning. No material change to control or ownership concentration is evident.

TL;DR: Transaction is routine, immaterial to UNH capitalization and unlikely to influence market perception.

The reported acquisition of 11 vested dividend-equivalent shares at no cash cost increases the reporting person’s direct beneficial ownership to 2,761 shares, with additional indirect holdings noted. The entry price of $0 and the explanatory remark confirm these units arose from compensation vesting rather than an open-market purchase. Given the small absolute size relative to UnitedHealth’s market cap, this filing is informational and not material for valuation or trading decisions.

Paul R. Garcia, un direttore di UnitedHealth Group Inc. (UNH), ha riportato un'acquisizione interna il 23/09/2025 che consisteva in 11 azioni ordinarie registrate come acquisite a $0 come dividendi equiparati su azioni differite maturate. Il deposito mostra 2.761 azioni detenute beneficiariamente direttamente dopo la transazione e ulteriori detenzioni indirette di 2.146 azioni tramite un Trust revocabile più 45 e 55 azioni tramite due altri trust. Gli equivalenti a dividendi si sono maturati immediatamente e hanno gli stessi termini delle unità azionarie differite sottostanti.

Paul R. Garcia, un director de UnitedHealth Group Inc. (UNH), reportó una adquisición interna el 23/09/2025 que consistió en 11 acciones comunes registradas como adquiridas a $0 como equivalentes en dividendos sobre unidades de acciones diferidas vestidas. El registro muestra 2.761 acciones poseídas beneficiosamente directamente después de la operación y participaciones indirectas adicionales de 2.146 acciones a través de un fideicomiso revocable más 45 y 55 acciones a través de dos otros fideicomisos. Los equivalentes de dividendos se adjudicaron de inmediato y tienen los mismos términos que las unidades de acciones diferidas subyacentes.

폴 R. 가르시아, UnitedHealth Group Inc.(UNH)의 이사, 2025년 9월 23일에 주식 단위를 11주의 일반 주식으로 내부 취득을 보고했으며 이는 $0로 기록된 배당금 상당액으로 부여된 가속 vesting 주식단위에 속합니다. 신고서에 거래 직후 직접적으로 유리하게 소유한 2,761주의 보유 주식과, 해지 가능한 신탁을 통한 2,146주의 간접 보유, 그리고 두 개의 다른 신탁을 통한 4555주의 보유가 추가로 기재되어 있습니다. 배당금 상당액은 즉시 부여되었고 기초가 되는 지연 보상 주식단위와 동일한 조건을 가집니다.

Paul R. Garcia, directeur chez UnitedHealth Group Inc. (UNH), a déclaré une acquisition interne le 23/09/2025 consistant en 11 actions ordinaires enregistrées comme acquises pour $0 en tant qu’équivalents de dividende sur des unités d’actions différées acquises. Le dossier indique 2 761 actions détenues directement après la transaction et des positions indirectes supplémentaires de 2 146 actions via une fiducie révocable ainsi que 45 et 55 actions via deux autres fiducies. Les équivalents de dividendes se sont acquis immédiatement et conservent les mêmes conditions que les unités d’actions différées sous-jacentes.

Paul R. Garcia, ein Direktor der UnitedHealth Group Inc. (UNH), meldete eine interne Übernahme am 23.09.2025, die aus 11 Stammaktien bestand, die als zugewiesen zu $0 als Dividendenäquivalente auf vested deferred stock units verbucht wurden. Die Einreichung zeigt 2.761 Aktien, die unmittelbar nach der Transaktion direkt vorteilshaft gehalten werden, sowie zusätzliche indirekte Bestände von 2.146 Aktien über einen widerruflichen Trust sowie 45 und 55 Aktien über zwei weitere Trusts. Die Dividendenäquivalente wurden sofort fällig und behalten dieselben Bedingungen wie die zugrunde liegenden deferred stock units.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
GARCIA PAUL R

(Last) (First) (Middle)
C/O UNITEDHEALTH GROUP INCORPORATED
1 HEALTH DRIVE

(Street)
EDEN PRAIRIE MN 55344

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/23/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/23/2025 A 11(1) A $0 2,761 D
Common Stock 2,146 I By Revocable Trust
Common Stock 45 I By Trust 2
Common Stock 55 I By Trust 3
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.
Remarks:
Faraz A. Choudhry, Attorney-in-Fact for Paul R. Garcia 09/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Paul R. Garcia report on the UNH Form 4?

He reported acquisition of 11 common stock units as dividend equivalents that vested immediately, increasing direct ownership to 2,761 shares.

Why is the price listed as $0 on the Form 4 for UNH?

The $0 price reflects that the shares were issued as dividend equivalents on vested deferred stock units, not purchased for cash.

Does this Form 4 indicate a significant change in insider ownership for UNH?

No; the filing shows a small issuance of 11 shares and overall beneficial ownership remains modest, so it is not a material ownership change.

What indirect holdings does Paul R. Garcia have according to the filing?

The filing lists 2,146 shares held via a revocable trust and additional indirect holdings of 45 and 55 shares via two other trusts.

When was the reported transaction executed?

The transaction date reported is 09/23/2025 and the Form 4 was signed on 09/25/2025 by an attorney-in-fact.
Unitedhealth Gp

NYSE:UNH

UNH Rankings

UNH Latest News

UNH Latest SEC Filings

UNH Stock Data

312.96B
897.88M
0.82%
86.64%
1.32%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
EDEN PRAIRIE